You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 11, November 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Vignettes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Is the Combination of Tetracycline and Nicotinamide Therapy Alone Effective in Pemphigus?

Erkan Alpsoy, MD
Department of Dermatology Akdeniz University Medical Faculty 07070 Antalya, Turkey

Ertan Yilmaz, MD; Erdal Basaran, MD; Sahin Yazar, MD; Lütfiye Cetin, MD
Antalya

Arch Dermatol. 1995;131(11):1339-1340.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The combination of tetracycline and nicotinamide has been used with varying degrees of success in the treatment of bullous pemphigoid,1 dermatitis herpetiformis,2 and linear IgA bullous dermatosis.3,4 In addition, this combination has been reported to be effective for pemphigus.3 The primary advantage of tetracycline and nicotinamide therapy compared with the other classic forms is a lower toxicity and broader safety profile.1-3 The present study was undertaken to investigate whether the combination of tetracycline and nicotinamide alone is effective in the treatment of pemphigus.

Patients and Method.

Fifteen patients, 10 with pemphigus vulgaris (PV), one with pemphigus vegetans (PVeg), two with pemphigus foliaceus (PF), and two with pemphigus erythematosus (PE), were enrolled in the study.

The diagnosis was based on clinical examination and histopathologic and direct immunofluorescence studies.

The patients were administered 2 g of tetracycline and 1.5 g of nicotinamide per day during the 2-month treatment period. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.